Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 3
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E, Toledano-Fonseca M, Costa-Fraga N, García-Ortiz MV, Díaz-Lagares Á, Rodríguez-Ariza A, Aranda E, López-López R. Brozos-Vázquez E, et al. Among authors: toledano fonseca m. Cancer Treat Rev. 2024 Apr;125:102719. doi: 10.1016/j.ctrv.2024.102719. Epub 2024 Mar 12. Cancer Treat Rev. 2024. PMID: 38490088 Free article. Review.
Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer.
Mena-Osuna R, Mantrana A, Guil-Luna S, Sánchez-Montero MT, Navarrete-Sirvent C, Morales-Ruiz T, Rivas-Crespo A, Toledano-Fonseca M, García-Ortíz MV, García-Jurado G, Gómez-España MA, González-Fernández R, Villar C, Medina-Fernández FJ, Villalba JM, Aranda E, Rodríguez-Ariza A. Mena-Osuna R, et al. Among authors: toledano fonseca m. J Pathol. 2023 Jul;260(3):261-275. doi: 10.1002/path.6080. Epub 2023 Apr 5. J Pathol. 2023. PMID: 37017456
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
García-Ortiz MV, Cano-Ramírez P, Toledano-Fonseca M, Cano MT, Inga-Saavedra E, Rodríguez-Alonso RM, Guil-Luna S, Gómez-España MA, Rodríguez-Ariza A, Aranda E. García-Ortiz MV, et al. Among authors: toledano fonseca m. Clin Epigenetics. 2023 Jul 22;15(1):118. doi: 10.1186/s13148-023-01535-4. Clin Epigenetics. 2023. PMID: 37481552 Free PMC article.
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Guil-Luna S, Rivas-Crespo A, Navarrete-Sirvent C, Mantrana A, Pera A, Mena-Osuna R, Toledano-Fonseca M, García-Ortíz MV, Villar C, Sánchez-Montero MT, Krueger J, Medina-Fernández FJ, De La Haba-Rodríguez J, Gómez-España A, Aranda E, Rudd CE, Rodríguez-Ariza A. Guil-Luna S, et al. Among authors: toledano fonseca m. Biomed Pharmacother. 2023 Nov;167:115592. doi: 10.1016/j.biopha.2023.115592. Epub 2023 Sep 29. Biomed Pharmacother. 2023. PMID: 37778272 Free article.
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Élez E, Gómez-España MA, Grávalos C, García-Alfonso P, Ortiz-Morales MJ, Losa F, Díaz IA, Graña B, Toledano-Fonseca M, Valladares-Ayerbes M, Polo E, Salgado M, Martínez de Castro E, Safont MJ, Salud A, Ruiz-Casado A, Tabernero J, Riesco MDC, Rodriguez-Ariza A, Aranda E. Élez E, et al. Among authors: toledano fonseca m. Br J Cancer. 2022 Apr;126(6):874-880. doi: 10.1038/s41416-021-01638-w. Epub 2021 Dec 22. Br J Cancer. 2022. PMID: 34937947 Free PMC article. Clinical Trial.
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab.
Ortiz-Morales MJ, Toledano-Fonseca M, Mena-Osuna R, Cano MT, Gómez-España A, Haba-Rodríguez JR, Rodríguez-Ariza A, Aranda E. Ortiz-Morales MJ, et al. Among authors: toledano fonseca m. Cancers (Basel). 2022 Jun 21;14(13):3054. doi: 10.3390/cancers14133054. Cancers (Basel). 2022. PMID: 35804826 Free PMC article.
Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells.
López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, Conde F, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. López-Sánchez LM, et al. Among authors: toledano fonseca m. Lab Invest. 2021 Mar;101(3):292-303. doi: 10.1038/s41374-020-00507-z. Epub 2020 Dec 1. Lab Invest. 2021. PMID: 33262438 Free article.
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts.
Guil-Luna S, Mena R, Navarrete-Sirvent C, López-Sánchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Díaz C, Medina-Fernández FJ, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Guil-Luna S, et al. Among authors: toledano fonseca m. Front Med (Lausanne). 2020 Jul 3;7:264. doi: 10.3389/fmed.2020.00264. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32719800 Free PMC article.
11 results